To the content
1 . 2017

Whether to follow clinical guidelines on anticoagulant therapy at patient with atrial fibrillation and hemolytic anemia?

AbstractThe article deals with the case of hemolytic anemia development in patient with atrial fibrillation (AF) and discussion of opportunities of pharmacological correction by anticoagulants taking into account their importance and therapeutic expediency of use.

Keywords:atrial fibrillation, hemolytic anemia, anticoagulant therapy

DOI: 10.24411/2309-1908-2017-00018


All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Andrey G. Obrezan
MD, Professor, Head of the Hospital Therapy Department of the Saint Petersburg State University, Chief Physician of SOGAZ MEDICINE Clinical Group, St. Petersburg, Russian Federation

Journals of «GEOTAR-Media»